COVID-19 represents an unprecedented health, social and economic challenge in Australia and around the world. Support Burnet’s COVID-19 emergency response today.
BACKGROUND: Anemia is a major complication of vivax malaria. Anti-phosphatidylserine (PS) antibodies generated during falciparum malaria mediate phagocytosis of uninfected red blood cells (RBCs) that expose PS, and have been linked to late malarial-anemia. However, their role in anemia from non-falciparum Plasmodium species is not known, nor their role in early anemia from falciparum malaria. METHODS: We measured PS-IgG and IgM antibodies in Malaysian patients with vivax, falciparum, knowlesi and malariae malaria, and in healthy controls, and correlated with hemoglobin. PS antibodies were also measured in volunteers experimentally infected with P. vivax and P. falciparum. RESULTS: PS-IgM and IgG were elevated in patients with vivax, falciparum, knowlesi and malariae malaria (p<0.0001 for all comparisons with controls), and were highest in vivax malaria. In vivax and falciparum malaria, PS-IgM and IgG on admission correlated inversely with admission and nadir hemoglobin, controlling for parasitemia and fever duration. PS-IgM and IgG were also increased in volunteers infected with blood-stage P. vivax and P. falciparum, and were higher in P. vivax infection. CONCLUSIONS: PS antibodies are higher in vivax than falciparum malaria, correlate inversely with hemoglobin and may contribute to the early loss of uninfected-RBC found in malarial anemia from both species.